BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

October 24, 2023 Comments Off on BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS

–  Resource consumption will be reduced by 50% to accelerate ALS development –  Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS NEW YORK, Oct. 24,…